What is the prevalence of non-adherence to antihypertensive medication among hypertensive patients in India?
Nearly half of hypertensive patients in India are non-adherent to their medication, with significant regional variations, highlighting the need for localized adherence-improving strategies.
INTRODUCTION: Hypertension is a major contributor to disability-adjusted life years (DALYs) worldwide, as highlighted by the Global Burden of Disease study (GBD 2021). Effective management of hypertension through medication can significantly lower the risks associated with the condition. It is important to recognize that not adhering to antihypertensive therapy often leads to negative health outcomes. METHODS: statistic, with a significance level set at p North > West > South (p < 0.01). A higher prevalence was also observed in community settings (51%) and rural areas (57%). DISCUSSION: Findings of this study shed light on the growing prevalence of nonadherence to antihypertensive medication among Indian hypertensive patients. Nonadherence patterns vary across settings and contexts, reinforcing the need for more longitudinal studies and context-specific targeted interventions. Subgroup analyses revealed no significant reduction in heterogeneity, highlighting the need for more qualitative studies. CONCLUSION: Given the high and regionally variable prevalence of non-adherence to antihypertensive medication in India, it is crucial to develop localized strategies to improve adherence to hypertension treatment.
Sandeep et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: